CD8A and neoplasm: With a low tumor mutation burden (TMB) value, the patient presented a very high percentage of CD8<sup>+</sup>PD-L1<sup>+</sup> T cells that infiltrated in the baseline tissue, with 95.5% of all CD8+ cells expressing PD-L1 and a low percentage of CD8+ T cells expressing PD-1.